Cargando…

The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study

BACKGROUND: Systemic corticosteroids (SC) are an integral part of managing acute exacerbations of COPD (AECOPD). However, the optimal dose and duration vary widely in clinical practice. We hypothesized that the use of a “PowerPlan” order set in the electronic health system (EHS) that includes a 5-da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gulati, Swati, Zouk, Aline N, Kalehoff, Jonathan P, Wren, Christopher S, Davison, Peter N, Kirkpatrick, Denay Porter, Bhatt, Surya P, Dransfield, Mark T, Wells, James Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067788/ https://www.ncbi.nlm.nih.gov/pubmed/30100717 http://dx.doi.org/10.2147/COPD.S165665

Ejemplares similares

Life-Space mobility and clinical outcomes in COPD
por: Iyer, Anand S, et al.
Publicado: (2018)

Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study
por: Gulati, Swati, et al.
Publicado: (2019)

Determinants of successful completion of pulmonary rehabilitation in COPD
por: Brown, Angel T, et al.
Publicado: (2016)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Determinants of arterial stiffness in COPD
por: Bhatt, Surya P, et al.
Publicado: (2014)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study
por: Zouk, Aline N., et al.
Publicado: (2020)

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit
por: Ruparel, Mamta, et al.
Publicado: (2016)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2018)

Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPD
por: Sharifov, Oleg F, et al.
Publicado: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
por: Morjaria, Jaymin B., et al.
Publicado: (2017)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
por: Gong, Yaya, et al.
Publicado: (2022)

Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test
por: Dai, Meng-Yuan, et al.
Publicado: (2015)

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort
por: Busch, Robert, et al.
Publicado: (2016)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Reply to Moy: Not All Home-based Exercise Programs Are Home-based Pulmonary Rehabilitation Programs
por: Bhatt, Surya P., et al.
Publicado: (2019)

Reply to Gagnon et al.: Video Teleheath and Pulmonary Rehabilitation: Need for a Better Understanding
por: Bhatt, Surya P., et al.
Publicado: (2020)

COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates
por: Parikh, Raj, et al.
Publicado: (2016)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
por: Wells, J Michael, et al.
Publicado: (2013)

The role of combination therapy with corticosteroids and long-acting β(2)-agonists in the prevention of exacerbations in COPD
por: Cazzola, Mario, et al.
Publicado: (2006)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPD
por: Rho, Ji Young, et al.
Publicado: (2018)

Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD
por: Cuttica, Michael J, et al.
Publicado: (2017)

Rome Criteria for Exacerbation of Chronic Obstructive Pulmonary Disease: Not Built in a Day
por: Bhatt, Surya P.
Publicado: (2022)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines
por: Laue, Johanna, et al.
Publicado: (2015)

Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients
por: Abroug, Fekri, et al.
Publicado: (2014)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
por: Camp, James, et al.
Publicado: (2018)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Managing complications of percutaneous tracheostomy and gastrostomy
por: Zouk, Aline N., et al.
Publicado: (2021)

Tailoring of corticosteroids in COPD management
por: De Coster, Daan A., et al.
Publicado: (2014)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e89qgufqk4lfs5rlvjs8vmebtr